Bioventus Total Current Liabilities from 2010 to 2024
| BVS Stock | USD 11.50 0.21 1.79% |
Total Current Liabilities | First Reported 2010-12-31 | Previous Quarter 175.5 M | Current Value 148.1 M | Quarterly Volatility 71.6 M |
Check Bioventus financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bioventus' main balance sheet or income statement drivers, such as Depreciation And Amortization of 40.7 M, Interest Expense of 42.7 M or Total Revenue of 386.8 M, as well as many indicators such as Price To Sales Ratio of 0.61, Dividend Yield of 4.0E-4 or PTB Ratio of 1.81. Bioventus financial statements analysis is a perfect complement when working with Bioventus Valuation or Volatility modules.
Bioventus | Total Current Liabilities |
Latest Bioventus' Total Current Liabilities Growth Pattern
Below is the plot of the Total Current Liabilities of Bioventus over the last few years. Total Current Liabilities is an item on Bioventus balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Bioventus are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. It is the total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations. Bioventus' Total Current Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Bioventus' overall financial position and show how it may be relating to other accounts over time.
| Total Current Liabilities | 10 Years Trend |
|
Total Current Liabilities |
| Timeline |
Bioventus Total Current Liabilities Regression Statistics
| Arithmetic Mean | 104,323,534 | |
| Geometric Mean | 88,034,647 | |
| Coefficient Of Variation | 68.60 | |
| Mean Deviation | 54,595,512 | |
| Median | 65,428,000 | |
| Standard Deviation | 71,568,961 | |
| Sample Variance | 5122.1T | |
| Range | 251.9M | |
| R-Value | 0.76 | |
| Mean Square Error | 2340.5T | |
| R-Squared | 0.58 | |
| Significance | 0 | |
| Slope | 12,142,407 | |
| Total Sum of Squares | 71709.6T |
Bioventus Total Current Liabilities History
About Bioventus Financial Statements
Bioventus shareholders use historical fundamental indicators, such as Total Current Liabilities, to determine how well the company is positioned to perform in the future. Although Bioventus investors may analyze each financial statement separately, they are all interrelated. The changes in Bioventus' assets and liabilities, for example, are also reflected in the revenues and expenses on on Bioventus' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Total Current Liabilities | 175.5 M | 148.1 M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Bioventus Stock Analysis
When running Bioventus' price analysis, check to measure Bioventus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bioventus is operating at the current time. Most of Bioventus' value examination focuses on studying past and present price action to predict the probability of Bioventus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bioventus' price. Additionally, you may evaluate how the addition of Bioventus to your portfolios can decrease your overall portfolio volatility.